International Stem Cell CORP (ISCO) stock
ISCOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.28+0.00 (+0.89%)
Close on Oct 19, 2026Market cap $2.27MP/E –Yield –
International Stem Cell profit margin
Profit margin (net margin) is net income as a percentage of revenue.
International Stem Cell's profit margin for the twelve months ending Jun 30, 2026 was -6.1%. For fiscal 2025 it was -4.6%, against -2.3% the year before. The highest annual figure on record is -1.7% in fiscal 2023.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -4.6% | −2.3 |
| FY2024 | Dec 31, 2024 | -2.3% | −0.6 |
| FY2023 | Dec 31, 2023 | -1.7% | +2.4 |
| FY2022 | Dec 31, 2022 | -4.0% | +8.5 |
| FY2021 | Dec 31, 2021 | -12.5% | +25.7 |
| FY2020 | Dec 31, 2020 | -38.2% | +6.8 |
| FY2019 | Dec 31, 2019 | -45.0% | −25.8 |
| FY2018 | Dec 31, 2018 | -19.2% | +62.2 |
| FY2017 | Dec 31, 2017 | -81.4% | −66.3 |
| FY2016 | Dec 31, 2016 | -15.1% | +19.8 |
| FY2015 | Dec 31, 2015 | -34.9% | +142.9 |
| FY2014 | Dec 31, 2014 | -177.8% | −7.4 |
| FY2013 | Dec 31, 2013 | -170.5% | +44.8 |
| FY2012 | Dec 31, 2012 | -215.3% | −12.9 |
| FY2011 | Dec 31, 2011 | -202.4% | +609.1 |
| FY2010 | Dec 31, 2010 | -811.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -2.7% | −7.9 |
| Q1 FY2026 | Mar 31, 2026 | -9.5% | +2.5 |
| Q4 FY2025 | Dec 31, 2025 | -16.1% | −16.6 |
| Q3 FY2025 | Sep 30, 2025 | 2.4% | +8.1 |
| Q2 FY2025 | Jun 30, 2025 | 5.3% | +0.2 |
| Q1 FY2025 | Mar 31, 2025 | -12.0% | −2.0 |
| Q4 FY2024 | Dec 31, 2024 | 0.4% | +24.7 |
| Q3 FY2024 | Sep 30, 2024 | -5.7% | +0.9 |
| Q2 FY2024 | Jun 30, 2024 | 5.1% | −21.6 |
| Q1 FY2024 | Mar 31, 2024 | -10.1% | −8.4 |
| Q4 FY2023 | Dec 31, 2023 | -24.2% | −25.2 |
| Q3 FY2023 | Sep 30, 2023 | -6.6% | +13.5 |
| Q2 FY2023 | Jun 30, 2023 | 26.7% | +26.8 |
| Q1 FY2023 | Mar 31, 2023 | -1.6% | −1.2 |
| Q4 FY2022 | Dec 31, 2022 | 0.9% | −10.8 |
| Q3 FY2022 | Sep 30, 2022 | -20.1% | +16.0 |
| Q2 FY2022 | Jun 30, 2022 | -0.1% | +48.7 |
| Q1 FY2022 | Mar 31, 2022 | -0.4% | +36.3 |
| Q2 FY2021 | Jun 30, 2021 | 11.8% | +71.7 |
| Q1 FY2021 | Mar 31, 2021 | -36.1% | −20.3 |
| Q4 FY2020 | Dec 31, 2020 | -48.8% | +46.8 |
| Q3 FY2020 | Sep 30, 2020 | -36.7% | −36.9 |
| Q2 FY2020 | Jun 30, 2020 | -59.9% | −32.0 |
| Q1 FY2020 | Mar 31, 2020 | -15.8% | +25.0 |
| Q4 FY2019 | Dec 31, 2019 | -95.6% | −49.4 |
| Q3 FY2019 | Sep 30, 2019 | 0.1% | −3.6 |
| Q2 FY2019 | Jun 30, 2019 | -27.9% | −14.9 |
| Q1 FY2019 | Mar 31, 2019 | -40.8% | −9.3 |
| Q4 FY2018 | Dec 31, 2018 | -46.2% | +29.2 |
| Q3 FY2018 | Sep 30, 2018 | 3.8% | +121.0 |
| Q2 FY2018 | Jun 30, 2018 | -13.0% | −45.2 |
| Q1 FY2018 | Mar 31, 2018 | -31.5% | +122.3 |
| Q4 FY2017 | Dec 31, 2017 | -75.4% | −203.3 |
| Q3 FY2017 | Sep 30, 2017 | -117.2% | −138.5 |
| Q2 FY2017 | Jun 30, 2017 | 32.2% | −537.6 |
| Q1 FY2017 | Mar 31, 2017 | -153.8% | – |
| Q4 FY2016 | Dec 31, 2016 | 127.9% | – |
| Q3 FY2016 | Sep 30, 2016 | 21.3% | – |
| Q2 FY2016 | Jun 30, 2016 | 569.9% | – |
See a number that looks wrong?